Immune-related adverse events and the balancing act of immunotherapy COMMENT

被引：180

作者：

Conroy, Michael ^{[1
,2
,3
]}

Naidoo, Jarushka ^{[1
,2
,3
,4
]}

机构：

[1] Beaumont RCSI Canc Ctr, Dublin, Ireland

[2] Beaumont Hosp, Dublin, Ireland

[3] RCSI Univ Hlth Sci, Dublin, Ireland

[4] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA

来源：

NATURE COMMUNICATIONS | 2022年 / 13卷 / 01期

关键词：

PNEUMONITIS;

D O I：

10.1038/s41467-022-27960-2

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The benefit from immune checkpoint inhibitors is tempered by immunologic toxicities, which involve diverse organs, have varying biology, onset time, and severity. Herein, we identify important areas of controversy and open research questions in the field of immune-related toxicity.

引用

页数：4

共 50 条

[31] Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?
Kostine, Marie
Cappelli, Laura C.
Calabrese, Cassandra
Calabrese, Leonard H.
Bingham, Clifton O., III
Richez, Christophe
Gottenberg, Jacques-Eric
Lambotte, Olivier
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (06) : 860 - +
[32] Multisystem immune-related adverse events from dual agent immunotherapy use
Li, Yuchen
Pond, Gregory Russell
McWhirter, Elaine
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] Immune-related adverse events in patients treated with immunotherapy according to corticosteroid exposure
Meraz-Brenez, Andres
Aranda-Gutierrez, Alejandro
Jael Soliz, Dhylan
Reyes-Vanegas, Diego
Gonzalez-Sanchez, Hector Raul
Martinez-Cannon, Bertha Alejandra
Verduzco-Aguirre, Haydee Cristina
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[34] Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy
Ezponda Casajus, A.
Calvo Imirizaldu, M.
de Torres Tajes, J. P.
Garcia-Baizan, A.
Castanon Alvarez, E.
Cano Rafart, D.
Vivas Perez, I
Bastarrika Aleman, G.
RADIOLOGIA, 2020, 62 (02): : 131 - 138
[35] Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist
Jamal, Shahin
Hudson, Marie
Fifi-Mah, Aurore
Ye, Carrie
JOURNAL OF RHEUMATOLOGY, 2020, 47 (02) : 166 - 175
[36] The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
Coschi, Courtney H.
Juergens, Rosalyn A.
CURRENT ONCOLOGY, 2021, 28 (06) : 4392 - 4407
[37] Association of Adjuvant Immunotherapy Duration With Chronic Immune-Related Adverse Events Reply
Johnson, Douglas B.
Patrinely, J. Randall, Jr.
Ye, Fei
JAMA ONCOLOGY, 2021, 7 (10) : 1574 - 1575
[38] Immune-related adverse events and immunotherapy efficacy in patients with cancer: A retrospective study
Prather, Lyndsey L.
Ali, Atif
Wang, Hannah
Du, Wendy
Chen, Nan
Sheth, Aakash
Sandulache, Vlad
Sabichi, Anita Lyn
Kemnade, Jan Ole
Wang, Daniel Ying
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[39] Long-term immune-related adverse events after discontinuation of immunotherapy
Horisberger, Karoline
Portenkirchner, Carmen
Rickenbacher, Andreas
Biedermann, Luc
Gubler, Christoph
Turina, Matthias
IMMUNOTHERAPY, 2021, 13 (09) : 735 - 740
[40] Immune-related adverse events secondary to immunotherapy in oncology A guide for general practice
Yeoh, Hui-Ling
Freilich, Karen
Voskoboynik, Mark
Moore, Maggie
Andrews, Miles C.
Shackleton, Mark
Haydon, Andrew M.
AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2023, 52 (06) : 378 - 385

← 1 2 3 4 5 →